JP Morgan Chase’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Hold
0
7462
2025
Q4
Hold
0
7361
2025
Q3
Hold
0
7353
2025
Q2
Hold
0
7019
2025
Q1
Hold
0
7265
2024
Q4
Hold
0
7339
2024
Q3
Hold
0
7353
2024
Q2
Hold
0
7217
2024
Q1
Hold
0
7199
2023
Q4
Hold
0
7174
2023
Q3
Hold
0
6918
2023
Q2
Hold
0
6648
2023
Q1
Hold
0
6908
2022
Q4
Hold
0
6720
2022
Q3
Hold
0
6604
2022
Q2
Hold
0
6628
2022
Q1
Hold
0
6757
2021
Q4
Hold
0
6764
2021
Q3
Hold
0
6607
2021
Q2
Hold
0
6247
2021
Q1
Sell
-2
Closed -$439K 5539
2020
Q4
$341K Buy
2
+1
+100% +$155K ﹤0.01% 4577
2020
Q3
$80K Hold
1
﹤0.01% 4794
2020
Q2
$73K Buy
+1
New +$122K ﹤0.01% 4683

Other funds holding GNPX

JP Morgan Chase's GNPX Position: Q1 2026 in Review

JP Morgan Chase held its Genprex (GNPX) position steady in Q1 2026 at 0 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #7462.

JP Morgan Chase first reported a position in GNPX in Q2 2020 and has held it in 3 quarters since. The position peaked at $341K in Q4 2020. 15 funds tracked by Wall St. Rank hold GNPX as of Q1 2026.

  • JP Morgan Chase held 0 shares of Genprex worth $4 as of Q1 2026.
  • JP Morgan Chase left its Genprex share count unchanged in Q1 2026.
  • Genprex made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7462 holding.
  • JP Morgan Chase first reported a position in Genprex in Q2 2020 and has held it in 3 quarters since.
  • JP Morgan Chase's Genprex position peaked at $341K in Q4 2020.
  • 15 funds tracked by Wall St. Rank held Genprex as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.